Rakuten Securities’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.04K Buy
31
+30
+3,000% +$6.22K ﹤0.01% 531
2026
Q1
$224 Sell
1
-68
-99% -$16.9K ﹤0.01% 792
2025
Q4
$16.6K Buy
69
+2
+3% +$511 0.01% 356
2025
Q3
$18.3K Buy
67
+55
+458% +$15K 0.01% 331
2025
Q2
$3.1K Buy
12
+9
+300% +$2.15K ﹤0.01% 555
2025
Q1
$672 Hold
3
﹤0.01% 702
2024
Q4
$686 Hold
3
﹤0.01% 650
2024
Q3
$732 Sell
3
-13
-81% -$2.9K ﹤0.01% 606
2024
Q2
$3.06K Buy
16
+13
+433% +$2.64K ﹤0.01% 441
2024
Q1
$594 Hold
3
﹤0.01% 605
2023
Q4
$516 Buy
+3
New +$461 ﹤0.01% 521

Other funds holding RMD

Rakuten Securities's RMD Position: Q2 2026 in Review

Rakuten Securities increased its ResMed (RMD) stake by 3,000% in Q2 2026, buying an estimated $6.22K and bringing the position to 31 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Rakuten Securities first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.3K in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Rakuten Securities held 31 shares of ResMed worth $6.04K as of Q2 2026.
  • Rakuten Securities bought 30 ResMed shares in Q2 2026, an estimated $6.22K.
  • ResMed made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #531 holding.
  • Rakuten Securities first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's ResMed position peaked at $18.3K in Q3 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.